Canada markets closed

EV Biologics, Inc. (YECO)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.6221+0.0200 (+3.32%)
At close: 03:04PM EDT

EV Biologics, Inc.

1621 Central Avenue
Cheyenne, WY 82001
United States
206-734-4738
https://www.evbiologics.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 284

Key Executives

NameTitlePayExercisedYear Born
Mr. Daniel S. McKinneyFounder, Chairman & CEON/AN/A1962
Mr. Monte FisherChief Financial OfficerN/AN/AN/A
Mr. William BossungCorporate Finance Director & Corporate SecretaryN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics, Inc. in August 2020. EV Biologics, Inc. was incorporated in 2011 and is headquartered in Cheyenne, Wyoming.

Corporate Governance

EV Biologics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.